Narrow search
Showing 11 - 20 of 137,518
Cover Image
Regulation and welfare : evidence from Paragraph IV generic entry in the pharmaceutical industry
Branstetter, Lee; Chatterjee, Chirantan; Higgins, Matthew J. - 2011
Persistent link: https://www.econbiz.de/10009234148
Cover Image
Pharmaceutical followers
Arcidiacono, Peter; Ellickson, Paul B.; Landry, Peter; … - 2013
Persistent link: https://www.econbiz.de/10010200106
Cover Image
Pharmaceutical followers
Arcidiacono, Peter; Ellickson, Paul B.; Landry, Peter; … - In: International journal of industrial organization 31 (2013) 5, pp. 538-553
Persistent link: https://www.econbiz.de/10010248454
Cover Image
Pharmaceutical followers
Arcidiacono, Peter; Ellickson, Paul B.; Landry, Peter; … - 2013
We estimate a model of drug demand and supply that incorporates insurance, advertising, and competition between branded and generic drugs within and across therapeutic classes. We use data on antiulcer drugs from 1991 to 2010. Our simulations show generics and "me-too" drugs each increased...
Persistent link: https://www.econbiz.de/10010250679
Cover Image
Side effects of generic competition?
Hellström, Jörgen; Rudholm, Niklas - In: The European journal of health economics : HEPAC ; … 5 (2004) 3, pp. 203-208
Persistent link: https://www.econbiz.de/10002388617
Cover Image
The long shadow of patent expiration : generic entry and Rx-to-OTC switches
Berndt, Ernst R.; Kyle, Margaret K.; Ling, Davina C. - In: Scanner data and price indexes, (pp. 229-267). 2003
Persistent link: https://www.econbiz.de/10001832900
Cover Image
The impact of generic competition on brand name market shares : evidence from micro data
Aronsson, Thomas; Bergman, Mats A.; Rudholm, Niklas - In: The Swedish pharmaceuticals market : essays on entry, …, (pp. 1-13). 2001
Persistent link: https://www.econbiz.de/10001573284
Cover Image
Pharmaceutical Followers
Arcidiacono, Peter - 2013
We estimate a model of drug demand and supply that incorporates insurance, advertising, and competition between branded and generic drugs within and across therapeutic classes. We use data on antiulcer drugs from 1991 to 2010. Our simulations show generics and ``me-too'' drugs each increased...
Persistent link: https://www.econbiz.de/10013074647
Cover Image
Patents as a spur to subsequent innovation? : evidence from pharmaceuticals
Gilchrist, Duncan Sheppard - In: American economic journal : a journal of the American … 8 (2016) 4, pp. 189-221
Persistent link: https://www.econbiz.de/10011572039
Cover Image
Pharmaceutical Followers
Arcidiacono, Peter - 2013
We estimate a model of drug demand and supply that incorporates insurance, advertising, and competition between branded and generic drugs within and across therapeutic classes. We use data on antiulcer drugs from 1991 to 2010. Our simulations show generics and ``me-too'' drugs each increased...
Persistent link: https://www.econbiz.de/10012459141